Methyl 4-biphenylcarboxylate, 99.0%, 50g

(3-(2-Aminophenyl)-1H-pyrazol-5-yl)methanol, 97.0%, 25g

(4-Ethoxy-3,5-dimethylphenyl)boronic acid, 95.0%, 1g

5-BROMO-3-NITROBENZENE-1,2-DIOL, 95.0%, 1g

1-ethyl-4-methyl-1H-indole-2-carboxylic acid, 95.0%, 2g

6-BROMO-3-(PIPERIDIN-1-YLMETHYL)-1H-INDOLE, 95.0%, 5g

Joints à vis de laboratoire GL 14, 1,6 mm, 2 pièce(s)

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)butanoic acid, 98+%, 1g

2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 1g

(2,5-Dimethylphenyl)methanol, 95%, 10g

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 1mg

5-Bromo-2-(oxetan-3-yloxy)aniline, 95%, 2.5g

5-Methoxybenzo[d]oxazole-2(3H)-thione, 95.0%, 5g